A5113785331- Cardiac Structural Anomalies and Repair
- Cardiomyopathy and Myosin Studies
- Mechanical Circulatory Support Devices
- Viral Infections and Immunology Research
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Transplantation: Methods and Outcomes
- COVID-19 Clinical Research Studies
- Cardiovascular Effects of Exercise
- Renal Transplantation Outcomes and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrest and Resuscitation
- Cancer Treatment and Pharmacology
- Cardiovascular Issues in Pregnancy
- Abdominal Trauma and Injuries
- Amyloidosis: Diagnosis, Treatment, Outcomes
- COVID-19 and healthcare impacts
- Pulmonary Hypertension Research and Treatments
- Abdominal vascular conditions and treatments
- SARS-CoV-2 detection and testing
- Parathyroid Disorders and Treatments
- SARS-CoV-2 and COVID-19 Research
- Cardiac Valve Diseases and Treatments
- Chemotherapy-induced cardiotoxicity and mitigation
Prince Sultan University
2019-2024
King Abdullah Medical City
2024
McGill University Health Centre
2017
Royal Victoria Hospital
2017
Royal Victoria Regional Health Centre
2017
The Proprotein convertase subtilisin/ kexin type 9 inhibitors (PCSK9i) are a novel class of lipid-lowering agents that effectively reduce low-density lipoprotein (LDL) cholesterol levels. use these has expanded to involve recipients solid organ transplants. Method: This case series reports the safety using PCSK9i in three patients who received heart transplants, followed up for lipid profile, and observed incidence coronary artery vasculopathy (CAV) over two years post-treatment. Results:...
This study compares the prevalence of titin gene mutations in patients with dilated cardiomyopathy receiving standard pharmacological therapy and without recovery systolic function.
Background: Tricuspid valve regurgitation may affect the outcomes after heart transplantation. There is a paucity of data reporting transplants in our region. The objectives this study were to report occurrence tricuspid transplantation, its course, and effect on survival.
Transthyretin cardiac amyloidosis (ATTRCA) is a prevalent disease, and it can be associated with heart failure (HF), left ventricle hypertrophy (LVH), atrial fibrillation (AF), aortic stenosis (AS). The study aims to detect the prevalence of ATTRCA in symptomatic AS population. A single-center prospective screening for patients diagnosed severe undergoing valve (AV) intervention. total 27 were enrolled, which 15 (56%) men. mean age was 72.8 ± 10.5 years. HF symptoms present 11 (40.7%) at New...
Right heart failure (RHF) is a complex syndrome and carries worse prognosis. The studies are limited in identifying gender differences clinical imaging findings of RHF. Method: retrospective review patients presenting with Results: 966 were reviewed; women accounted for 570 (59%) mean age was 57±16 years. most common co-morbidity included diabetes 419 (43%), class II obesity 323 (33.5%), atrial fibrillation 409 (42%). preserved ejection fraction (HFpEF) the dominant phenotype 601 (62%)....
The Coronavirus disease 2019 (COVID-19) pandemic led to global and national rapid health system changes treat the affected patients prevent spread of virus. social distancing, redirecting resources, nationwide lockdown cancellation non-urgent hospital visits interruption continuity care for with chronic cardiac conditions such as heart failure (HF). This consensus document addresses domains delivery that are by pandemic. It explains current situation further recommendation on how overcome...
Abstract Solid-organ transplant patients have a high risk of severe infection related to acute respiratory syndrome coronavirus-2 (SARS-Cov-2). This case represents 54-year-old woman known as diabetic, hypothyroidism, and recent heart recipient who presented with 1-week history cough fatigue. She was hypoxic on presentation the hospital progressively declined required invasive mechanical ventilation. had distress hypoxia chest x-ray showed progressive bilateral infiltrates. leukopenia 3.5...
Abstract Funding Acknowledgements The Rosenfeld Heart Fund Introduction recovery of left ventricle (LV) systolic function with normalization ejection fraction (LVEF) occurs in 10 - 27% patients 80% maintaining recovery. However, the need for medical therapy after is often questioned. Previous randomized studies treatment withdrawal were small, not selected non-ischemic dilated cardiomyopathy (DCM) and had a reference improved or recovered EF to > 40% 10% change from LVEF at time...
Management of patients with end-stage heart failure is still challenging. We report a case idiopathic dilated cardiomyopathy who went through challenging course. The was presented as acute syndrome, which rapidly declined into cardiogenic shock and cardiac arrest that required an extracorporeal membrane oxygenator, then biventricular assist device implantation for circulatory support. course complicated severe gastrointestinal bleeding multiorgan until achieving full organ recovery. left...